• Infectology Specialty, INNSZ.
  • Specialty in Internal Medicine, INNSZ.
  • Surgeon, National Autonomous University of Mexico.

Academic appointments:

  • Head of the Department of Infectious Diseases of the National Cancer Institute
  • National Research System.
  • Researcher affiliated with CISIDAT.

Research interests:

  • Infectious diseases, especially HIV.
  • Oncogenic human papillomavirus and HIV co-infection in Mexican women.

Featured projects:

  • She has participated since 1990 as a CENSIDA advisor on issues related to clinical patient management.
  • She has been involved in legislative work to establish preventive policies to control hospital infections and against the Infectious Biological Waste law.


  • High Phenotypic and Genotypic Diversity of Enterococcus faecium from Clinical and Commensal Isolates in Third Level Hospital. Mayoral-Terán C, Flores-Moreno K, Cevallos MA, Volkow-Fernández P, Castillo-Ramírez S, Graña-Miraglia L, López-Vidal Y. Microb Drug Resist. 2019 Sep 23.
  • Infectious complications as a predictor of mortality in patients with non-hodgkin lymphoma receiving rituximab-containing chemotherapy. Meza-Meneses P, Cornejo-Juárez P, Vilar-Compte D, Volkow-Fernández P. Rev Invest Clin. 2019;71(4):275-282.
  • Successive complications after anterior cervical fixation: pharyngoesophageal diverticulum, fistulization, and cervical spondylitis by Streptococcus milleri – case report and literature review. Volkow-Fernández P, Islas-Muñoz B, Santillán-Doherty P, Estrada-Lobato E, Alva-López L, Ávila-Ramírez J. J Med Case Rep. 2019 Apr 30;13(1):129.
  • Non-AIDS defining cancer (NADC) among HIV-infected patients at an oncology tertiary-care center in Mexico. Cornejo-Juárez P, Cavildo-Jerónimo D, Volkow-Fernández P. AIDS Res Ther. 2018 Oct 27;15(1):16.
  • [Multidrug resistance E-ESKAPE strains isolated from blood cultures in patients with cancer]. Velázquez-Acosta C, Cornejo-Juárez P, Volkow-Fernández P. Salud Publica Mex. 2018 Mar-Apr;60(2):151-157.
  • Streptococcus pneumoniae: distribution of serotypes and antimicrobial susceptibility in patients with cancer. Soto-Noguerón A, Carnalla-Barajas MN, Cornejo-Juárez P, Volkow-Fernández P, Velázquez-Meza ME; Grupo SIREVA-México, Echániz-Aviles G. Salud Publica Mex. 2018 Jan-Feb;60(1):21-28.
  • Bloodstream infections in cancer patients. Risk factors associated with mortality. Islas-Muñoz B, Volkow-Fernández P, Ibanes-Gutiérrez C, Villamar-Ramírez A, Vilar-Compte D, Cornejo-Juárez P. Int J Infect Dis. 2018 Jun;71:59-64. doi: 10.1016/j.ijid.2018.03.022. Epub 2018 Apr 9.
  • Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years. Velázquez-Acosta C, Zarco-Márquez S, Jiménez-Andrade MC, Volkow-Fernández P, Cornejo-Juárez P. Support Care Cancer. 2018 Jun;26(6):1953-1960. doi: 10.1007/s00520-017-4032-x. Epub 2018 Jan 7.
  • Rapid Gene Turnover as a Significant Source of Genetic Variation in a Recently Seeded Population of a Healthcare-Associated Pathogen. Graña-Miraglia L, Lozano LF, Velázquez C, Volkow-Fernández P, Pérez-Oseguera Á, Cevallos MA, Castillo-Ramírez S. Front Microbiol. 2017 Sep 20;8:1817.
  • Infectious Complications and Multidrug-Resistant Bacteria in Patients With Hematopoietic Stem Cell Transplantation in the First 12 Months After Transplant. César-Arce A, Volkow-Fernández P, Valero-Saldaña LM, Acosta-Maldonado B, Vilar-Compte D, Cornejo-Juárez P. Transplant Proc. 2017 Jul – Aug;49(6):1444-1448.